Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125132142 | 12513214 | 2 | F | 20130717 | 20160712 | 20160630 | 20160912 | PER | US-JNJFOC-20160525777 | JANSSEN | 86.19 | YR | E | M | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125132142 | 12513214 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | IN VARYING DOSES OF 15 MG AND 20 MG | Y | N | UNKNOWN | 0 | TABLET | ||||||
| 125132142 | 12513214 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125132142 | 12513214 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | IN VARYING DOSES OF 15 MG AND 20 MG | Y | N | UNKNOWN | 0 | TABLET | ||||||
| 125132142 | 12513214 | 4 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 22406 | 15 | MG | TABLET | |||||
| 125132142 | 12513214 | 5 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | U | 0 | 81 | MG | UNSPECIFIED | QD | ||||||
| 125132142 | 12513214 | 6 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 125132142 | 12513214 | 7 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 125132142 | 12513214 | 8 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | AS NEEDED | U | 0 | 375 | MG | UNSPECIFIED | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125132142 | 12513214 | 1 | Pulmonary embolism |
| 125132142 | 12513214 | 2 | Pulmonary embolism |
| 125132142 | 12513214 | 3 | Deep vein thrombosis |
| 125132142 | 12513214 | 4 | Deep vein thrombosis |
| 125132142 | 12513214 | 5 | Product used for unknown indication |
| 125132142 | 12513214 | 6 | Pulmonary embolism |
| 125132142 | 12513214 | 7 | Deep vein thrombosis |
| 125132142 | 12513214 | 8 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125132142 | 12513214 | OT |
| 125132142 | 12513214 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125132142 | 12513214 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125132142 | 12513214 | 1 | 201307 | 20140527 | 0 | |
| 125132142 | 12513214 | 2 | 201307 | 201307 | 0 | |
| 125132142 | 12513214 | 3 | 201307 | 20140527 | 0 | |
| 125132142 | 12513214 | 4 | 201307 | 201307 | 0 | |
| 125132142 | 12513214 | 6 | 201307 | 201307 | 0 | |
| 125132142 | 12513214 | 7 | 201307 | 201307 | 0 |